U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 10 of 112 results

Status:
US Approved Rx (2006)
First approved in 2006

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ciclesonide is a glucocorticoid receptor agonist indicated for the treatment of allergic rhinitis (Omnaris nasal spray) and asthma (Alvesco). It was also developed by Byk Gulden for chronic obstructive pulmonary disease (COPD), but no development had...
Status:
US Approved Rx (2007)
First approved in 1997

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefdinir is an extended-spectrum, semisynthetic cephalosporin, for oral administration. As with other cephalosporins, bactericidal activity of cefdinir results from inhibition of cell wall synthesis. Cefdinir is stable in the presence of some, but no...
Status:
US Approved Rx (2020)
First approved in 1996

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefepime is a fourth-generation cephalosporin antibiotic, which was developed in 1994. Cefepime has a broad spectrum in vitro activity that encompasses a wide range of Gram-positive and Gram-negative bacteria. Within bacterial cells, the molecular ta...
Status:
US Approved Rx (2007)
First approved in 1992

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefpodoxime is an orally administered, extended spectrum, semi-synthetic antibiotic of the cephalosporin class. Cefpodoxime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefpodoxime has activity in the presence of ...
Status:
US Approved Rx (2018)
First approved in 1991

Class (Stereo):
CHEMICAL (ABSOLUTE)



Azithromycin is one of the world's best-selling antibiotics, used to treat or prevent certain bacterial infections: Acute bacterial exacerbations of chronic bronchitis in adults; acute bacterial sinusitis in adults; uncomplicated skin and skin struct...
Status:
US Approved Rx (2013)
First approved in 1986

Class (Stereo):
CHEMICAL (ABSOLUTE)



Cefixime, an antibiotic, is a third-generation cephalosporin like ceftriaxone and cefotaxime. Cefixime is highly stable in the presence of beta-lactamase enzymes. As a result, many organisms resistant to penicillins and some cephalosporins due to the...
Status:
US Approved Rx (1986)
First approved in 1985

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftazidime is a semisynthetic, broad-spectrum, beta-lactam antibiotic, used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime is used to treat lower respiratory tract, skin, urinary tract, blood-strea...
Status:
US Approved Rx (2007)
First approved in 1985

Class (Stereo):
CHEMICAL (EPIMERIC-AXIAL)



Cefotetan is a semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positi...
Status:
US Approved Rx (2016)
First approved in 1984

Class (Stereo):
CHEMICAL (ABSOLUTE)



Ceftriaxone is a broad-spectrum cephalosporin antibiotic with a very long half-life. Ceftriaxone is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Ceftriaxone has activity in the presence of some beta-lactamases, both ...
Status:
US Approved Rx (2017)
First approved in 1981

Class (Stereo):
CHEMICAL (ABSOLUTE)



Piperacillin is a semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic which exerts bactericidal activity by inhibiting septum formation and cell wall synthesis of susceptible bacteria. Piperacillin sodium salt is used in com...